Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia

Abstract The pandemic of SARSCov2 infection has created a challenge in health services worldwide. Some scales have been applied to evaluate the risk of intubation, such as the ROX and HACOR. The objective of this study is to compare the predictive capacity of the HACOR scale and the ROX index and de...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carlos Fernando Valencia, Oscar David Lucero, Onofre Casas Castro, Andrey Alexandrovich Sanko, Peter Alfonso Olejua
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b9f0894fba194c508518a9c2fd0c6c92
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b9f0894fba194c508518a9c2fd0c6c92
record_format dspace
spelling oai:doaj.org-article:b9f0894fba194c508518a9c2fd0c6c922021-11-21T12:17:56ZComparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia10.1038/s41598-021-02078-52045-2322https://doaj.org/article/b9f0894fba194c508518a9c2fd0c6c922021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02078-5https://doaj.org/toc/2045-2322Abstract The pandemic of SARSCov2 infection has created a challenge in health services worldwide. Some scales have been applied to evaluate the risk of intubation, such as the ROX and HACOR. The objective of this study is to compare the predictive capacity of the HACOR scale and the ROX index and define the optimal cut-off points. Study of diagnostic tests based on a retrospective cohort. Composite outcome was the proportion of patients that needed endotracheal intubation (ETI) or died of COVID19 pneumonia. Discrimination capacity was compared by the area under the curve of each of the two scales and the optimal cut-off point was determined using the Liu method. 245 patients were included, of which 140 (57%) required ETI and 152 (62%) had the composite end result of high-flow nasal cannula (HFNC) failure. The discrimination capacity was similar for the two scales with an area under receiver operating characteristic curve of 0.71 and 0.72 for the HACOR scale for the ROX index, respectively. The optimal cut-off point for the ROX index was 5.6 (sensitivity 62% specificity 65%), while the optimal cut-off point for the HACOR scale was 5.5 (sensitivity 66% specificity 65%). The HACOR scale and the ROX index have a moderate predictive capacity to predict failures to the HFNC strategy. They can be used in conjunction with other clinical variables to define which patients may require invasive mechanical ventilation.Carlos Fernando ValenciaOscar David LuceroOnofre Casas CastroAndrey Alexandrovich SankoPeter Alfonso OlejuaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Carlos Fernando Valencia
Oscar David Lucero
Onofre Casas Castro
Andrey Alexandrovich Sanko
Peter Alfonso Olejua
Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia
description Abstract The pandemic of SARSCov2 infection has created a challenge in health services worldwide. Some scales have been applied to evaluate the risk of intubation, such as the ROX and HACOR. The objective of this study is to compare the predictive capacity of the HACOR scale and the ROX index and define the optimal cut-off points. Study of diagnostic tests based on a retrospective cohort. Composite outcome was the proportion of patients that needed endotracheal intubation (ETI) or died of COVID19 pneumonia. Discrimination capacity was compared by the area under the curve of each of the two scales and the optimal cut-off point was determined using the Liu method. 245 patients were included, of which 140 (57%) required ETI and 152 (62%) had the composite end result of high-flow nasal cannula (HFNC) failure. The discrimination capacity was similar for the two scales with an area under receiver operating characteristic curve of 0.71 and 0.72 for the HACOR scale for the ROX index, respectively. The optimal cut-off point for the ROX index was 5.6 (sensitivity 62% specificity 65%), while the optimal cut-off point for the HACOR scale was 5.5 (sensitivity 66% specificity 65%). The HACOR scale and the ROX index have a moderate predictive capacity to predict failures to the HFNC strategy. They can be used in conjunction with other clinical variables to define which patients may require invasive mechanical ventilation.
format article
author Carlos Fernando Valencia
Oscar David Lucero
Onofre Casas Castro
Andrey Alexandrovich Sanko
Peter Alfonso Olejua
author_facet Carlos Fernando Valencia
Oscar David Lucero
Onofre Casas Castro
Andrey Alexandrovich Sanko
Peter Alfonso Olejua
author_sort Carlos Fernando Valencia
title Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia
title_short Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia
title_full Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia
title_fullStr Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia
title_full_unstemmed Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia
title_sort comparison of rox and hacor scales to predict high-flow nasal cannula failure in patients with sars-cov-2 pneumonia
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/b9f0894fba194c508518a9c2fd0c6c92
work_keys_str_mv AT carlosfernandovalencia comparisonofroxandhacorscalestopredicthighflownasalcannulafailureinpatientswithsarscov2pneumonia
AT oscardavidlucero comparisonofroxandhacorscalestopredicthighflownasalcannulafailureinpatientswithsarscov2pneumonia
AT onofrecasascastro comparisonofroxandhacorscalestopredicthighflownasalcannulafailureinpatientswithsarscov2pneumonia
AT andreyalexandrovichsanko comparisonofroxandhacorscalestopredicthighflownasalcannulafailureinpatientswithsarscov2pneumonia
AT peteralfonsoolejua comparisonofroxandhacorscalestopredicthighflownasalcannulafailureinpatientswithsarscov2pneumonia
_version_ 1718419089802657792